&Partners’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.8K Buy
+12,773
New +$37.4K ﹤0.01% 2639

Other funds holding EDIT

&Partners's EDIT Position: Q3 2026 in Review

&Partners opened a new position in Editas Medicine (EDIT) in Q3 2026: 12,773 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #2639 among its holdings.

220 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • &Partners held 12,773 shares of Editas Medicine worth $32.8K as of Q3 2026.
  • Editas Medicine was a new &Partners position in Q3 2026.
  • Editas Medicine made up ﹤0.01% of &Partners's portfolio in Q3 2026, its #2639 holding.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on &Partners's 13F filing for Q3 2026, filed 16 Nov 2026.